Skip to main content
Download PDF

Differential DNA methylation and lymphocyte proportions in a Costa Rican high longevity region

Epigenetics & Chromatin volume 10, Article number: 21 (2017) Cite this article

Abstract

Background

The Nicoya Peninsula in Costa Rica has one of the highest old-age life expectancies in the world, but the underlying biological mechanisms of this longevity are not well understood. As DNA methylation is hypothesized to be a component of biological aging, we focused on this malleable epigenetic mark to determine its association with current residence in Nicoya versus elsewhere in Costa Rica. Examining a population’s unique DNA methylation pattern allows us to differentiate hallmarks of longevity from individual stochastic variation. These differences may be characteristic of a combination of social, biological, and environmental contexts.

Methods

In a cross-sectional subsample of the Costa Rican Longevity and Healthy Aging Study, we compared whole blood DNA methylation profiles of residents from Nicoya (n = 48) and non-Nicoya (other Costa Rican regions, n = 47) using the Infinium HumanMethylation450 microarray.

Results

We observed a number of differences that may be markers of delayed aging, such as bioinformatically derived differential CD8+ T cell proportions. Additionally, both site- and region-specific analyses revealed DNA methylation patterns unique to Nicoyans. We also observed lower overall variability in DNA methylation in the Nicoyan population, another hallmark of younger biological age.

Conclusions

Nicoyans represent an interesting group of individuals who may possess unique immune cell proportions as well as distinct differences in their epigenome, at the level of DNA methylation.

Background

Aging is a complex biological process that progressively leads to physiological decline and an increased risk of mortality. The genetic component of life span is approximated to be less than 30%, leaving the remainder to be determined by environmentally and socially influenced factors such as diet, exposure to infection, and lifestyle choices [1, 2]. While the mechanistic regulation of these non-genetic influences is poorly understood, previous work has suggested that epigenetic processes may be tightly interwoven with biological aging [3].

Epigenetics generally refers to the study of altered chromatin states, such as modifications to DNA and the proteins involved in its packaging and regulation. To date, DNA methylation (DNAm) is the most commonly studied epigenetic mark in human populations, as recent advances in technology have allowed for the inexpensive high-throughput measurement of >400,000 CpG sites across the genome. There are many other studied epigenetic processes, such as post-translational histone modifications, histone variants, and noncoding RNAs; however, these modifications have been more of a focus in model organism research and cancer biology.

DNAm is one type of epigenetic modification that impacts how genes are expressed and thus can have important phenotypic and functional consequences for an organism. Unlike the DNA sequence itself, DNAm is changeable through environmental influences over an individual’s life course. DNAm involves the covalent addition of a methyl group to the 5′ carbon of cytosine nucelotides, most often in the context of CpG dinucleotides (cytosine–phosphate–guanine). Genetic variants, such as single nucleotide polymorphisms (SNPs), can affect DNAm at nearby CpG sites, called methylation quantitative trait loci (mQTL) [4]. DNAm also varies in association with environmental and behavioral factors, such as diesel exposure and smoking. Additionally, variability in DNAm accumulates across one’s entire life span, discussed in detail below. DNAm patterns are associated with altered gene activity. Shifts in DNAm levels may follow a change in gene expression, or may act in the recruitment of methylation-dependent transcription factors that regulate transcriptional machinery. Understanding the effect of environmental influences on DNAm is important for unraveling the intricate regulation of genes and possible functional consequences of these alterations.

Age-related DNAm encompasses at least two distinct phenomena. First, specific CpGs associated with chronological age have been identified and, in some cases, replicated in several human populations. These age-related DNAm signatures can be either tissue specific or occur across several tissue types [5]. The epigenetic clock is a tool based on CpGs that change with age. Epigenetic clocks are DNAm-based markers of biological age, either confined to a single tissue or consistently accurate across tissues [6,7,8]. Deviations from these epigenetic age estimates, referred to as a measure of age acceleration, have been associated with an increased risk of all-cause mortality, time until death, and frailty [9,10,11]. Second, variability increases with age due to stochastic non-site-specific changes in DNAm, a process referred to as epigenetic drift [12].

It is critical to address cell-type heterogeneity when investigating DNAm patterns in tissues containing mixed cell types. Not only does cell type change over one’s life span but it is also the primary source of variation in DNAm across healthy individuals. DNAm profiles obtained from identical cell types, but separate individuals, show higher similarity than two different cell types from the same individual [13]. Given that isolating DNA from a single cell type is not always feasible or that cell count information is sometimes not available, bioinformatics-based methods have been developed to estimate cell-type proportions using DNAm profiles in blood and brain [14, 15]. The blood-based predictions are closely correlated with complete blood count measures, thus suggesting the validity of these methods to derive accurate blood count information bioinformatically [16]. It is also worth noting that measures of epigenetic age acceleration specific to whole blood have been defined to account for age-induced changes to cell-type proportions [6]. These measures are integral when analyzing DNAm from whole blood, as the proportion of certain blood cell types, such as CD8+ memory and naïve T cells, change with age [17].

Aging research in humans commonly investigates the unique biological and lifestyle characteristics of individuals surviving to old age [18]. An alternative approach, used in the current study design, is to examine the underlying biology of longevity by examining a population characterized as having a particularly high old-age life expectancy [19], the Nicoya region of Costa Rica, and comparing it to the rest of Costa Rica which has moderately lower life expectancy. By averaging out the stochastic variation in aging among individuals within each geographic region of the country, this approach offers a way to identify contextual (rather than individual) differences associated with healthy aging and longevity. While the method of examining area-based determinants of health and longevity has received substantial attention in biomedical research [20], a lack of appropriate data sources have limited its application in understanding the biological mechanisms of longevity.

The Nicoya peninsula of Costa Rica has been characterized by exceptionally high longevity, providing an intriguing framework to explore the relationship between DNAm and aging [21]. Mortality rates among elderly Costa Ricans in Nicoya are substantially lower than in the rest of Costa Rica, with individuals in Nicoya being some of the most long lived in the world. The relative mortality rate of Nicoya as compared to similar age cohorts in the rest of Costa Rica is 0.80. This advantage remains significant after statistical control for level of education and type of health insurance [21]. The Nicoyan advantage is particularly evident in cardiovascular disease, despite the fact that risk factors like smoking, physical activity and systolic blood pressure are similar throughout Costa Rica. One key indicator of the Nicoyan advantage is longer knee height—an anthropometric biomarker that is associated with early childhood environment [22]. Nicoyans also have lower BMI, waist circumference, and, among men, lower levels of HbA1c, glucose, triglycerides and total/HDL cholesterol ratio [21]. We have previously shown that leukocyte telomere length, an aging biomarker, also has more favorable (longer) levels among Nicoyans compared to individuals in the rest of Costa Rica [23].

In this study, we examined DNAm in a nationally representative population of Costa Ricans, investigating potential biological differences that may help explain the higher longevity observed in Nicoyans as compared to other Costa Ricans. We focused on DNAm, as this epigenetic mark can be modified by environmental influences, has the potential to regulate gene expression, and most importantly, has an established relationship with aging across the mammalian life span. Using genome-wide DNAm patterns to predict blood cell-type composition, we determined differential estimated proportions of age-related immune cells. While we did not observe differences in epigenetic age acceleration, we did find significantly decreased DNAm variability in Nicoyans. Finally, we identified DNAm patterns unique to Nicoyans, at both genomic regions and specific CpG sites. Understanding DNAm patterns between Nicoyans and other Costa Ricans (non-Nicoyans) will offer new insights both into the role of DNAm in aging and perhaps help to illuminate why Nicoyans have among the longest old-age life expectancies.

Results

Cohort characteristics and DNA methylation data

We examined a subset of samples from the Costa Rican Study on Longevity and Healthy Aging (CRELES), a longitudinal, nationally representative, and probabilistic sample of close to 3000 adults aged 60 years and over that were collected mostly in 2005, with over-sampling of older ages [24]. We assayed DNAm profiles of 48 Nicoyans (longevity group) and 47 non-Nicoyans (control group). In order to maximize statistical power for our age-based hypothesis, we randomly sampled half of the individuals between the ages of 60 and 75 and the other half aged 95 and above, selecting an equal number in each age category among Nicoyans and non-Nicoyans to have an age-matched sample. Table 1 shows the mean characteristics of these populations. Nicoyans tend to have lower levels of education and lower wealth than non-Nicoyans, but are similar on observed health-related characteristics. We obtained DNAm profiles from whole blood using the Infinium HumanMethylation450 (450k) array, a genome-wide microarray that quantifies DNAm at over 485,000 sites. We applied data quality controls to remove poor performing probes, probes that hybridized the XY chromosomes, and probes predicted to cross-hybridize [25]. Our final dataset for subsequent analyses consisted of 441,109 sites.

Table 1 Cohort characteristics (means and percents), Nicoyans and non-Nicoyans
Full size table

Nicoyans had fewer estimated CD8+ memory and more naïve T cells than non-Nicoyans

Whole blood is a heterogeneous tissue containing certain cell types that change with age, with age-related decreases occurring in CD8+ T, CD4+ T and B lymphocytes, and the greatest increases in natural killer cells and monocytes [26]. To assess these differences in our cohort, we performed a previously described blood cell-type deconvolution [14] by using the DNAm profiles of each sample to estimate the proportions of granulocytes, natural killer cells, CD8+ T lymphocytes, CD4+ T lymphocytes, monocytes, and B lymphocytes. We found that Nicoyans had a significantly lower proportion of estimated CD8+ T cells when compared to non-Nicoyans (Kruskal–Wallis p value = 0.0038) (Fig. 1a). We also observed that Nicoyans had a higher mean level of estimated granulocyte proportions, although only reaching borderline significance (Kruskal–Wallis p value = 0.0486). It is important to note that we did not focus on the blood composition as a whole, as we were primarily interested in specific age-related cell-type trends.

Fig. 1
figure 1

Nicoyans had differential CD8+ naïve and memory T cell abundance levels. a Box plots demonstrating bioinformatically derived white blood cells in Nicoyans and non-Nicoyans. Cell proportions estimated using the Houseman method. Blue: Nicoyans, white: non-Nicoyans. The p value is derived from a nonparametric group comparison test using Kruskal–Wallis. b Box plots illustrating the relationship between the bioinformatically derived CD8+ naïve T cell and CD8+ memory T cell across Nicoyans and non-Nicoyans. c Scatter plots of chronological age plotted against each CD8+ naïve T cells and CD8+ memory T cells abundance level for each sample. CD8+ naïve T cell show a decrease with age, whereas CD8+ memory T cells increase with chronological age. Pearson’s r coefficients derived from log-transformed age correlated with each respective cell-type level. Blue: Nicoyans, black: non-Nicoyans. Line of best fit shown with 95% confident intervals shaded in respective group color. The scale of cell abundance is a measure from a bioinformatically derived prediction of the respective cell types using flow-sorted counts from other datasets to infer cellular proportions of that specific isolated cell type based on the DNA methylation data [9, 46, 47]

Full size image

To further investigate the differential proportion of estimated CD8+ T cells, we applied a more detailed cell deconvolution tool that provides an expanded estimation of CD8+ T naïve cells (CD8+ CD45RA+ CCR7+) and CD8+ T memory cells (CD8+ CD28− CD45RA−) [6]. CD8+ T memory cells typically increase with age, and CD8+ T naïve cells generally decrease with age through thymic involution [27]. Given that these measures are proportional and highly correlated, it is statistically appropriate to assess the ratio of CD8+ T naïve cells to CD8+ T memory cells (Additional file 1: Figure S1). Using this approach, we found a significant difference between Nicoyans and non-Nicoyans (Kruskal–Wallis p value = 0.0135). We observed a greater abundance of predicted CD8+ T naïve cells in Nicoyans and a lower abundance of estimated CD8+ T memory cells in Nicoyans, as compared to non-Nicoyans (Fig. 1b). These trends were suggestive of a younger immune cell profile in Nicoyans.

Pearson’s correlation coefficients were computed to assess the relationship between chronological age (log transformed) and the estimated proportion of each CD8+ T cell type (Fig. 1c). We observed a negative correlation between chronological age and CD8+ T naïve proportion (Nicoyans and non-Nicoyans; Pearson’s r = −0.55 and −0.61, respectively). As expected, there was a positive correlation between age and CD8+ T memory cells (Nicoyans and non-Nicoyans; Pearson’s r = 0.61, and 0.61, respectively; Fig. 1c), demonstrating a known immunological aging trend, but here based on epigenetic data. We found no significant difference in the regression slopes of chronological age on either CD8+ T cell type, when comparing Nicoyans to non-Nicoyans (p > 0.50); while we did observe differences in mean levels of both estimated CD8+ T cell types, we did not see any group difference in the nature of how these cell types changed across age.

Epigenetic age did not differ between Nicoyans and non-Nicoyans

Having established differences in estimated CD8+ T cell populations between the two groups, we next examined DNAm age as an established metric of biological aging. We examined DNAm age of Nicoyans compared to non-Nicoyans using three epigenetic clocks, which provided measures of biological age using DNAm levels at different groups of CpG sites (Fig. 2a) [6,7,8]. Across all samples, we found correlations between DNAm age and chronological age (Horvath: Pearson’s r = 0.86, Hannum: Pearson’s r = 0.85, Weidner: Pearson’s r = 0.86). However, we found no significant difference between Nicoyans and non-Nicoyans in terms of DNAm age (as calculated by each clock), while adjusting for chronological age (ANOVA p > 0.30, 95% CI for the Horvath clock was −6.3 to 3.8 years). We did, however, observe a mean difference of −6.9 years between epigenetic age and chronological age for all samples, suggesting that Costa Ricans, inclusive of both Nicoyans and non-Nicoyans, may on average be epigenetically younger than their chronological age (Fig. 2b). Furthermore, we reduced our data to only centenarians (age ≥ 100 years old), and the mean absolute difference between DNAm age and chronological age was −12.7 years.

Fig. 2
figure 2

DNA methylation age correlated with chronological age. a Left to right: Horvath age estimation method was used to derive DNA methylation (DNAm) age using 353 CpGs; Hannum method to estimate DNAm age using 71 CpGs, and the Weidner 99 CpG model. b Histogram of age acceleration difference (DNAm age–chronological age). Dotted line shows the mean of all samples

Full size image

We further examined biological age by assessing two other recently defined measures of age acceleration: intrinsic and extrinsic epigenetic acceleration, which are independent and dependent of blood cell-type proportions, respectively. We did not find any significant difference between Nicoyans and non-Nicoyans in any of these acceleration measures (ANOVA p ≥ 0.5, Additional file 2: Figure S2).

DNA methylation variability was lower in Nicoyans

After assessing whether any differences in epigenetic age existed, we next investigated epigenetic drift between Nicoyans and non-Nicoyans. We hypothesized that lower variability in Nicoyans would be representative of a biologically younger profile based on the epigenetic drift phenomenon where stochastic variation in DNAm occurs with age. We calculated the interquantile range (IQR) at each CpG site (90th–10th percentile) represented on the 450k array to account for outliers and found a significant variability difference between Nicoyans and non-Nicoyans (Wilcoxon signed-rank test; p < 2.2 × 10−16), with a lower level of total mean DNAm variation in Nicoyans (Fig. 3a). Furthermore, we assessed the level of DNAm variability across individuals between 60 and 80 years old and individuals >80 years old, in Nicoyans and non-Nicoyans. We found a lower DNAm variability in the younger group, in both populations. However, there was a greater difference between the non-Nicoyan old and young age groups compared to the Nicoyans respective age groups (non-Nicoya: IQR mean difference = 0.0065, p < 2.2 × 10−16, Nicoya: IQR mean difference = 0.0043, p = 1.79 × 10−10). Lastly, when a β value IQR threshold of ≥5% was applied to only variable sites, we found 129,971 and 146,047 variable sites in the >80-year-old range of Nicoyans and non-Nicoyans, respectively. For the younger age range, we found 116,038 and 120,711 sites that had greater than 5% IQR in Nicoyans and non-Nicoyans, respectively (Fig. 3b). In summary, we found a lower degree of DNAm variability was associated with Nicoyans for both age groups, 60–80 years old and >80 years old, when compared to non-Nicoyans.

Fig. 3
figure 3

DNA methylation variability was lower in Nicoyans. a Scatter plot of log-transformed interquantile range (IQR; 90th–10th) at each CpG, values generated independently in each Nicoyan and non-Nicoyan group. Blue 41,695 CpGs had higher variability in Nicoyans. Red 98,073 CpGs had higher variability in non-Nicoyans. Gray insignificant variability, less than 20% IQR between groups. Significance value from Wilcoxon signed-rank test of IQR values between Nicoyans and non-Nicoyans. b Number of sites with a β value IQR greater than 5% in each age group. Blue Nicoyans, gray non-Nicoyans. β values were corrected for cell-type proportions

Full size image

Unique region-based differential methylation in Nicoyans

We next investigated differentially methylated regions (DMRs) between Nicoyans and non-Nicoyans to identify unique epigenetic signatures that may be associated with the longevity observed in Nicoya. Using the R package ‘DMRcate,’ we found that in the comparison of Nicoyans and non-Nicoyans, 20 DMRs containing three or more CpG sites passed a false discovery rate of ≤0.05, as well as an arbitrary biological cutoff of a β value ≥ 5% between groups for at least one CpG site in each DMR (Table 2; Fig. 4; Additional file 3: Figure S3). Age, sex, and blood cell-type proportions were used as covariates. DMRs were associated with genes based on the closest proximity to a transcription start site (TSS). The mean length of the DMRs was 411 bp, with the shortest being 76 bp and the longest being 1416 bp. On average, out of the 20 DMRs observed, there were seven CpG sites per region, with a range from 3 to 16. Six DMRs were found within 1500 bp of a TSS associated with the following genes’ promoter region: Nudix Hydrolase 12 (NUDT12) (6 CpGs), Vault-RNA-2 (VTRNA2-1) (16 CpGs), Peptidase M20 Domain Containing 1 (PM20D1) (8 CpGs), Active BCR-Related (ABR) (3 CpGs), tRNA-Leu (5 CpGs), and LOC100128885 (uncharacterized) (3 CpGs). The majority of DMRs were found in intergenic regions (8/20) with an average number of four CpGs per DMR and average length of 267 bp. Four DMRs were found in the body (intragenic) of the following genes: Glutamate-rich protein 1 (ERICH1) (8 CpGs), Hook Microtubule Tethering Protein 2 (HOOK2) (4 CpGs), GATA2 Antisense RNA 1 (GATA2-AS1) (3 CpGs), and C15orf26 (uncharacterized) (4 CpGs). Two DMRs were found in the 3′end regions of Mitochondrial Ribosomal Protein L21 (MRPL21) (3 CpGs) and BolA family member 3 (BOLA3) (5 CpGs). The average absolute difference in DNAm between Nicoyans and non-Nicoyans was 7.9% when assessing the single CpG site for each DMR that showed the greatest difference between groups. When DNAm was averaged across the DMR per group, the mean β value difference was 5.9%.

Table 2 Differentially methylated genomic regions between Nicoyans and non-Nicoyans
Full size table
Fig. 4
figure 4

Significantly differentially methylated regions between Nicoyans and non-Nicoyans. Top six of 20 significant DMRs found using ‘DMRcate.’ Unadjusted β values are displayed on the y-axis and genomic distance (bp) to the most proximal gene transcriptional start site (TSS) is plotted on the x-axis. Blue Nicoyans, red non-Nicoyans. Group mean represented by respective colored line

Full size image

Site-specific differential methylation in Nicoyans and technical verification

To complement the region-specific analysis, we also assessed DNAm differences at the site-by-site level to identify any single sites that were differentially methylated in Nicoyans as compared to non-Nicoyans. By investigating site-specific changes, we did not limit ourselves to highly represented genomic regions on the 450k array. We performed an epigenome-wide association study using a linear model of population group regressed on M values at each CpG site, with sex, age, and blood cell-type proportions included as covariates (Additional file 4: Figure S4). We observed nine CpGs below a nominal p value significance threshold of p ≤ 5 × 10−7 (q value < 0.022, Table 3) that were differentially methylated between Nicoyans and non-Nicoyans. After applying a biological threshold similar to the DMRcate analysis, four CpG sites passed our significance criteria: cg02853387 (DSCAML1), cg02438481 (C6orf123), cg13979274 (OR10H1), cg26107275 (BC042649). Not surprisingly, the four significant CpG sites did not overlap with our DMR findings, as these single CpGs identified through the site-by-site analysis were either: (1) found in a genomic region with no proximal array probes, or (2) nearby CpGs sites were not significantly correlated. The nearest neighboring array-CpG probe was greater than 1 kb away for three out of the four significant CpG sites (cg02853387, cg13979274, and cg26107275). While for cg02438481, the closest array-CpG (cg00788354) was 324 bp away, it had a Pearson’s correlation of r < 0.10 and was not significantly differentially methylated between groups.

Table 3 Characteristics of four biologically and statistically significant DNA methylation sites between Nicoyans and non-Nicoyans
Full size table

We performed pyrosequencing, a targeted DNAm sequencing technology, to verify that our single differential DNAm results were reproducible using an independent platform. We designed assays to measure three CpG sites that were observed to have a significant between group (Nicoyans and non-Nicoyans) difference in DNAm of ≥5.0% (cg02853387, cg02438481, and cg13979274) (sequences listed in Additional file 6: Table S1). Correlation coefficients between the pyrosequencing and 450k array for each CpG site showed a strong concordance between the two technologies [r s  = 0.87 (cg02853387), r s = 0.92 (cg02438481), and r s = 0.88 (cg13979274)]. Bland–Altman plots were generated for each CpG site to illustrate the agreement between the two quantification techniques (Fig. 5). To verify our differential DNAm findings between Nicoyans and non-Nicoyans, we confirmed these associations by statistically regressing DNAm determined by pyrosequencing onto group status, while controlling for age, cell-type proportions, and sex. All three sites remained significantly different between Nicoyans and non-Nicoyans (Table 3; Fig. 5).

Fig. 5
figure 5

Pyrosequencing of significantly differentially methylated single CpGs. Left Bland–Altman plot of concordance between 450k array and pyrosequencing result for each CpG. Text labels represent sample IDs. Middle scatter plot displaying correlation between 450k array and pyrosequencing for each CpG. Spearman correlation coefficients shown. Right box plots of significant difference between Nicoyans and non-Nicoyans at each CpG site, measured using pyrosequencing. Significant value from regression model of CpG methylation on group status, while controlling for sex, age, and cell-type proportions

Full size image

Lastly, to determine whether a measure of genetic population structure was confounded with group (Nicoyans vs non-Nicoyans), we performed a post hoc analysis using ‘Epistructure’ [28]. Principal component analysis was completed on DNAm of CpGs previously identified as genetically informative loci. The first two principal components generated from this analysis have been proposed to confer composites of genetic structure to be used as covariates in a DNAm analysis. Using this technique, we did not observe a significant difference between the Epistructure principal components of the measures in Nicoyans and non-Nicoyans, while controlling for sex, age, and cell-type proportions (PC1: p = 0.60, PC2: p = 0.93, Additional file 5: Figure S5); therefore, we did not include these measures in our analyses.

Discussion

In this study, we investigated differential patterns of DNAm in a population with well-characterized high longevity: Nicoya, Costa Rica. We aimed to identify unique patterns of DNAm that may underlie biological pathways associated with the longevity observed in Nicoya. Our study sample was drawn from a nationally representative demographic study of Costa Ricans age 60 years and over, and we randomly sampled individuals from within Nicoya and the rest of Costa Rica who were aged 60–75 and 95 years and above in order to assess age-associated DNAm. We have four primary findings. First, we observed a bioinformatically inferred younger immune profile in Nicoyan individuals compared to those living in the rest of Costa Rica, finding cellular proportion differences in CD8+ naïve and CD8+ memory T cells. Next, we found a lower level of total mean DNAm variation in Nicoyans compared to non-Nicoyans. We found 20 DMRs and four single CpG sites that were differentially methylated between Nicoyans and non-Nicoyans. While any of these differences we observed may be due to genetic differences in the populations, the fact that we show that estimated genetic structure did not differ between Nicoyans and non-Nicoyans suggests that these biological differences are more likely to be the result of environmental differences between these two populations. Lastly, DNAm age was not significantly different between Nicoyans and non-Nicoyans, although Costa Ricans overall had a younger mean DNAm age than the mean chronological age.

Our finding of proportional differences in CD8+ naïve and CD8+ memory T cells is intriguing in the context of previous work from animal models and other human research that has established that these blood cell proportions change as a function of age. Specifically, the naïve T cell response diminishes with time as they are naturally replaced by memory T cells through age-related thymic involution [17, 29]. Therefore, younger immune profiles have been hypothesized to delay the onset of infection vulnerability and extend health span [30]. Interestingly, centenarian offspring have been investigated in this context and show this ‘youthful’ immune cell phenotype [31]. The fact that our work suggested that Nicoyans had a lower proportion of CD8+ T memory cells and higher CD8+ T naïve cells is interesting in the context of immunoaging and might be suggestive of an age-related immune phenotype in Nicoyans.

Given their lower mortality rate, we were surprised about the lack of differences in DNAm age between Nicoyans non-Nicoyans, especially given that this biological aging measure has been associated with many age-related conditions such as cognitive fitness decline, frailty, and mortality [9, 11, 32]. It is important to note, however, that we only had the statistical power to test for a very large difference in DNAm age, and our 95% confidence interval suggests that Nicoyan individuals could be up to 6 years younger in DNAm age. We calculated epigenetic age in our samples using three published DNAm age predictors and found no significant difference in these measures of biological age between Nicoyans and non-Nicoyans. Previous work found that peripheral blood mononuclear cells from the offspring of semi-super centenarians, in an Italian cohort, appear 5.1 years epigenetically younger than controls. Centenarians also were reportedly 8.6 years younger than their chronological age [33]. This is consistent with our population; when we collapsed the Nicoyan and non-Nicoyan groups, we found centenarians were 12.7 years epigenetically younger. Furthermore, all Costa Ricans were 6.9 years epigenetically younger than their chronological age. It is possible that this might reflect the recently reported epigenetically younger phenotype in Hispanic populations [34].

To examine age-associated DNAm variability, we assessed a measure of variance in Nicoyans and non-Nicoyans independently. We were able to demonstrate the phenomenon of epigenetic drift within each of these groups, as our sample consisted of two age ranges in each group. Additionally, we observed that DNAm variation was lower in Nicoyans, both in the ≤80-year-old and in the >80-year-old age groups, when compared to non-Nicoyans. Given that DNAm variability across individuals has been reported to increase with age, our finding may highlight an epigenetic characteristic of the longevity in Nicoyans [12]. Although the biological pre- and antecedents of increased DNAm variability are poorly understood, our findings suggest lower DNAm variability may be associated with lower mortality. Some explanations for this age-associated DNAm variability have been proposed, such that DNAm variability may result from a functional decline in DNAm maintenance machinery or that the variability is a product of environmental exposures over time [35].

We found 20 genomic regions and four single CpGs that were significantly differentially methylated between Nicoyans and non-Nicoyans. One such DMR contained six CpGs and was located in the promoter region of NUDT12, a gene encoding a protein shown in vitro to cleave NADH, NADPH, and NAD+ [36]. Given that NUDT12 may play a role in NAD metabolism, a regulatory process associated with health span and aging, it is consistent with the fact that DNAm may be involved in the regulation of this gene that may have downstream effects on NAD biosynthesis. Nicoyans had a lower level of DNAm in the promoter region of NUDT12, a signature often associated with higher gene expression. In addition to our DMR findings, we also found four individual sites to be both statistically and biologically significant, three of which existed in intergenic regions. We further investigated three of these CpGs by quantifying DNAm with pyrosequencing, allowing us to verify both the accuracy of the 450k array and the significant differences between Nicoyans and non-Nicoyans. However, it remains unclear whether differential DNAm of these single CpGs or DMRs, at the observed effect sizes (<10%), are sufficient to yield a biological change. Interpretation of these findings at a biological level will require future mechanistic experiments.

Our findings should be interpreted within the context of several limitations. One limitation was the lack of genotype information for these samples, as genetic variation is considerably associated with DNAm [37]. In order to reduce genetic heterogeneity, we restricted control sampling to areas within Costa Rica, but outside of Nicoya. Nicoyan status is determined as of the time of the survey, i.e., at older ages, not based on birth or life-course residence, but in our sample 44 out of 48 Nicoyan residents have lived there their entire lives. While there are no documented differences between the historical migration patterns of the inhabitants of Nicoya and the rest of Costa Rica, minor differences may exist. Therefore, we implemented a recently published tool to infer genetic information using DNAm data obtained from the 450k array called ‘Epistructure,’ a tool from the python package GLINT [28]. We found no significant difference in population structure measures between Nicoyans and non-Nicoyans and thus did not include these composite measures in our analyses. Another consideration of our study results is that we used a bioinformatics approach to predict CD8+ T cell proportions, which are relative compositional estimates. As these predictions do not estimate actual cell counts, the abundance of other cell types will affect the proportional estimate of the CD8+ T cells. Ideally, we will need to validate our findings using a quantitative approach, such as fluorescent-activated cell sorting, to obtain actual cell counts. We note, perhaps not surprisingly, that we did not observe a significant difference when we performed an overall compositional analysis of these predictions [38], meaning that the blood composition overall was not different between Nicoyans and non-Nicoyans. However, our findings are supported by using two separate reference-based approaches [6, 14], both of which identified CD8+ T cells as being significantly different between Nicoyans and non-Nicoyans. Furthermore, these bioinformatic cell-type proportion predictions have been well validated in the literature when compared to actual cell counts, and so we were confident that this approach reflected true cell-type proportions [16].

Conclusions

Our findings thus highlight DNAm as a potential factor underlying the unique longevity observed in Nicoya region of Costa Rica. This work also supports the demographic data on longevity as characterizing this population as unique. The specific differences in immune cell proportions we observed in Nicoyans will lay the framework for a validation study to observe whether cell-sorting experiments yield similar results. Additionally, the differential DNAm findings may provide a candidate list of CpGs to test for differences in other longevity populations. Lastly, upon validating our findings, our work will contribute to narrowing the focus of mechanistic studies to assess whether the DNAm differences we observed are involved in gene regulation that may alter gene expression trajectories.

Methods

Sample preparation and data collection

Whole blood was collected from participants and genomic DNA was extracted at the University of Costa Rica from 2 ml of frozen whole blood using the phenol–chloroform method. DNA was bisulfite converted with the Zymo Research EZ DNA Methylation™ Kit (Irvine, CA, USA). Approximately 160 ng of bisulfite-converted DNA from each sample, with the addition of one technical replicate, was randomized across eight 450k array BeadChips as well as sentrix row and run in one batch according to the manufacturer’s protocol (San Diego, CA, USA).

Qiagen Pyromark Assay Design 2.0 software (Hilden, Germany) was used to generate pyrosequencing assays targeted to three 450k array CpGs. Pyrosequencing was performed on the a Qiagen Pyromark™ Q96 (Hilden, Germany) according to manufacturer’s instructions. All primer sequences are listed in Additional file 6: Table S1.

Data preprocessing and normalization

Illumina GenomeStudio software (San Diego, CA, USA) was used to subtract background noise and color correct raw data using control probes. Data were extracted in the form of an average β value matrix and imported into R Statistical software for the remainder of data processing. Logit-transformed β values to M values, a less heteroscedastic value, were used for all statistical analyses, whereas β values were used for visualization purposes as they represent percent methylation (0 = no methylation, 1 = fully methylated). We have included a comparison table of β values compared to M values for CpGs identified in the site-specific differential methylation analysis (Additional file 7: Table S2).

All data processing and statistical analyses were implemented in R version 3.2.3. We removed a subset of probes that could potentially lead to erroneous results. These consisted of 65 SNP control probes, probes that were specific to either the X or Y sex chromosomes, probes with missing β values or with a detection p ≥ 0.01 in 5 or more samples, polymorphic CpG probes, and cross-hybridizing XY probes. The total number of probes post-filtering based on these criteria was 441,109 [25]. No sample outliers were removed, defined as having more than 5% of their total probes fail.

Subset-quantile within array normalization (SWAN) was used to account for type I and II probe differences on the 450k array [39]. Known technical variation (sentrix ID and position) was accounted for with the function ‘ComBat’ [40]. Confirmation of these corrections was assessed before and after using principal component analysis.

Estimation of blood cell proportions

A validated cellular deconvolution method was used to estimate cell-type proportions in each blood sample, namely CD4+ and CD8+ T cells, natural killer cells, B cells, monocytes and granulocytes [16]. The predicted abundance levels of CD8+ T naïve and CD8+ T memory were obtained from the ‘Advanced Blood Analysis’ of the online DNAm age predictor [6]. Significance values were generated from performing a Kruskal–Wallis test for each cell-type proportion by group.

Prediction of epigenetic age

Three epigenetic clocks were used to predict biological age. The ‘Horvath’ and ‘Hannum’ estimates were computed with the online epigenetic clock software [6, 7]. The ‘Weidner’ age prediction was generated using the previously described 99 CpG model [41]. We investigated, to the best of our ability, the possibility that this finding was due to a global batch effect influencing all samples by performing the DNAm age calculation on raw data, after SWAN normalization data, and again after ComBat correction. In all cases, the mean DNAm age for all Costa Ricans was younger than the mean chronological age. We chose to proceed with calculating DNAm age using the most corrected data as we expected data that is corrected for technical batch effects, inclusive of probe design and chip–chip variance, to best represent true biological signal.

DNA methylation analysis

The R package ‘DMRcate’ was used to find DMRs [42]. The DMRcate model contained Nicoya group, chronological age, sex, and estimated cell-type proportions. This tool uses a Gaussian kernel smoothing of DNAm across the genome. Benjamini–Hochberg (BH) method was applied with a threshold of ≤ 0.05 and a β value difference of ≥ 5% [43].

Site-specific differential DNAm analysis was conducted using moderated t-statistics with empirical Bayesian variation estimation using the bioconductor R package ‘limma’ with chronological age, sex, and cell-type proportions as covariates [44]. M values consisted of log-transformed β values to achieve a measure with uniform variation and decreased heteroscedasticity. Significance values were corrected for multiple testing using the BH method [43].

DNAm variability was calculated using the interquantile range (IQR) across the 90th and 10th percentiles of each group, independently, at each CpG. A significance value was generated by performing a Wilcoxon signed-rank test between groups.

Inferred genetic ancestry

Population structure was inferred using the ‘Epistructure’ command-line tool GLINT [28]. This method applies principal component analysis on a reference list of genetically informative 450k array probes. This tool suggests the top two principal components can infer genetic structure. Linear regression was used for comparison of each PC and group status, while adjusting for sex, cell-type proportions, and age.

Abbreviations

450k array:

Infinium HumanMethylation450 array

BH:

Benjamini and Hochberg

CpG:

cytosine–phosphate–guanine dinucleotide

DMR:

differentially methylated region

DNAm:

DNA methylation

FDR:

false discovery rate

IQR:

interquantile range

PCA:

principal component analysis

References

  1. Brooks-Wilson AR. Genetics of healthy aging and longevity. Hum Genet. 2013;132(12):1323–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Passarino G, De Rango F, Montesanto A. Human longevity: genetics or lifestyle? It takes two to tango. Immun Ageing. 2016;13(1):12.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Jones MJ, Goodman SJ, Kobor MS. DNA methylation and healthy human aging. Aging Cell. 2015;14(6):924–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Shoemaker R, Deng J, Wang W, Zhang K. Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. Genome Res. 2010;20(7):883–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Farré P, Jones MJ, Meaney MJ, Emberly E, Turecki G, Kobor MS. Concordant and discordant DNA methylation signatures of aging in human blood and brain. Epigenetics Chromatin. 2015;8(1):19.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49(2):359–67.

    Article  CAS  PubMed  Google Scholar 

  8. Weidner CI, Lin Q, Koch CM, Eisele L, Beier F, Ziegler P, et al. Aging of blood can be tracked by DNA methylation changes at just three CpG sites. Genome Biol. 2014;15(2):R24.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Marioni RE, Shah S, McRae AF, Chen BH, Colicino E, Harris SE, et al. DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol. 2015;16(1):25.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Chen BH, Marioni RE, Colicino E, Peters MJ, Ward-Caviness CK, Tsai P-C, et al. DNA methylation-based measures of biological age: meta-analysis predicting time to death. Aging. 2016;8(9):1844–65.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Breitling LP, Saum K-U, Perna L, Schöttker B, Holleczek B, Brenner H. Frailty is associated with the epigenetic clock but not with telomere length in a German cohort. Clin Epigenetics. 2016;8(1):21.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Martin GM. Epigenetic drift in aging identical twins. Proc Natl Acad Sci. 2005;102(30):10413–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Jones MJ, Islam SA, Edgar RD, Kobor MS. Adjusting for cell type composition in DNA methylation data using a regression-based approach. Methods Mol Biol. 2015;1589:99–106.

    Article  Google Scholar 

  14. Houseman E, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13(1):86.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Guintivano J, Aryee MJ, Kaminsky ZA. A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics. 2013;8(3):290–302.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Koestler DC, Christensen B, Karagas MR, Marsit CJ, Langevin SM, Kelsey KT, et al. Blood-based profiles of DNA methylation predict the underlying distribution of cell types: a validation analysis. Epigenetics. 2013;8(8):816–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, et al. Shortage of circulating naive CD8+ T cells provides new insights on immunodeficiency in aging. Blood. 2000;95(9):2860–8.

    CAS  PubMed  Google Scholar 

  18. Beekman M, Blanché H, Perola M, Hervonen A, Bezrukov V, Sikora E, et al. Genome-wide linkage analysis for human longevity: Genetics of Healthy Aging Study. Aging Cell. 2013;12(2):184–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Rose G. Sick individuals and sick populations. Int J Epidemiol. 2001;30(3):427–32 (discussion 433–4).

    Article  CAS  PubMed  Google Scholar 

  20. Diez Roux AV. Investigating neighborhood and area effects on health. Am J Public Health. 2001;91(11):1783–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rosero-Bixby L, Dow WH, Rehkopf DH. The Nicoya region of Costa Rica: a high longevity island for elderly males. Vienna Yearb Popul Res. 2013;11:109–36.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bogin B, Varela-Silva MI. Leg length, body proportion, and health: a review with a note on beauty. Int J Environ Res Public Health. 2010;7(3):1047–75.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rehkopf DH, Dow WH, Rosero-Bixby L, Lin J, Epel ES, Blackburn EH. Longer leukocyte telomere length in Costa Rica’s Nicoya Peninsula: a population-based study. Exp Gerontol. 2013;48(11):1266–73.

    Article  CAS  PubMed  Google Scholar 

  24. Rosero-Bixby L, Fernández X, Dow W, National Archive of Compuetrized Data on Aging, editors. CRELES: costa rican longevity and healthy aging study, 2005 (Costa Rica Estudio De Longevidad Y Envejecimiento Saludable) (ICPSR 26681). 2010. doi:10.3886/ICPSR26681.v2. http://www.icpsr.umich.edu/icpsrweb/NACDA/studies/26681/documentation%20.

  25. Price ME, Cotton AM, Lam LL, Farré P, Emberly E, Brown CJ, et al. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin. 2013;6(1):4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Jaffe AE, Irizarry RA. Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biol. 2014;15(2):R31.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Fagnoni FF, Vescovini R, Mazzola M, Bologna G, Nigro E, Lavagetto G, et al. Expansion of cytotoxic CD8+ CD28− T cells in healthy ageing people, including centenarians. Immunology. 1996;88(4):501–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Rahmani E, Shenhav L, Schweiger R, Yousefi P, Huen K, Eskenazi B, et al. Genome-wide methylation data mirror ancestry information. Epigenetics Chromatin. 2017;10:1.

  29. Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Gui J, Mustachio LM, Su D-M, Craig RW. Thymus size and age-related thymic involution: early programming, sexual dimorphism, progenitors and stroma. Aging Dis. 2012;3(3):280–90.

    PubMed  PubMed Central  Google Scholar 

  31. Pellicanò M, Buffa S, Goldeck D, Bulati M, Martorana A, Caruso C, et al. Evidence for less marked potential signs of t-cell immunosenescence in centenarian offspring than in the general age-matched population. J Gerontol A Biol Sci Med Sci. 2013. doi:10.1093/gerona/glt120.

    PubMed  Google Scholar 

  32. Marioni RE, Shah S, McRae AF, Ritchie SJ, Muniz-Terrera G, Harris SE, et al. The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936. Int J Epidemiol. 2015. doi:10.1093/ije/dyu277.

    PubMed  PubMed Central  Google Scholar 

  33. Horvath S, Pirazzini C, Bacalini MG, Gentilini D, Di Blasio AM, Delledonne M, et al. Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring. Aging. 2015;7(12):1159–70.

  34. Horvath S, Gurven M, Levine ME, Trumble BC, Kaplan H, Allayee H, et al. An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease. Genome Biol. 2016;17(1):171.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Shah S, McRae AF, Marioni RE, Harris SE, Gibson J, Henders AK, et al. Genetic and environmental exposures constrain epigenetic drift over the human life course. Genome Res. 2014;24(11):1725–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Garten A, Schuster S, Penke M, Gorski T, de Giorgis T, Kiess W. Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol. 2015;11(9):535–46.

    CAS  PubMed  Google Scholar 

  37. Banovich NE, Lan X, McVicker G, van de Geijn B, Degner JF, Blischak JD, et al. Methylation QTLs are associated with coordinated changes in transcription factor binding, histone modifications, and gene expression levels. Reddy TE, editor. PLoS Genet [Internet]. 2014;10(9):e1004663. http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25233095&retmode=ref&cmd=prlinks.

  38. van den Boogaart KG, Tolosana-Delgado R. Fundamental concepts of compositional data analysis. In: Gentleman R, Giovanni P, and Hornik, K, editors. Analyzing compositional data with R. Berlin: Springer; 2013. p. 13–50.

  39. Maksimovic J, Gordon L, Oshlack A. SWAN: subset-quantile within array normalization for Illumina Infinium HumanMethylation450 BeadChips. Genome Biol. 2012;13(6):R44.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118–27.

    Article  PubMed  Google Scholar 

  41. Lin Q, Weidner CI, Costa IG, Marioni RE, Ferreira MRP, Deary IJ, et al. DNA methylation levels at individual age-associated CpG sites can be indicative for life expectancy. Aging. 2016;8(2):394–401.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Peters TJ, Buckley MJ, Statham AL, Pidsley R, Samaras K, Lord RV, et al. De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin. 2015;8:6.

    PubMed  PubMed Central  Google Scholar 

  43. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9(7):811–8.

    Article  CAS  PubMed  Google Scholar 

  44. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3(1):Article 3–25.

  45. Rosero-Bixby L, Dow WH. Surprising SES gradients in mortality, health, and biomarkers in a Latin American population of adults. J Gerontol B Psychol Sci Soc Sci. 2009;64(1):105–17.

    Article  PubMed  Google Scholar 

  46. Horvath S, Ritz BR. Increased epigenetic age and granulocyte counts in the blood of Parkinson’s disease patients. Aging. 2015;7(12):1130–42.

  47. Horvath S, Levine AJ. HIV-1 infection accelerates age according to the epigenetic clock. J Infect Dis. 2015;212(10):1563–73.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Authors’ contributions

DHR, LMM, and MSK designed the research study. LMM performed all data analyses and wrote the manuscript together with DHR and MSK. AMM performed pyrosequencing assays. AMM and JLM performed DNAm microarray experiments. RDE provided statistical advice and assisted with data visualization. WHD and LRB designed the CRELES Study. MJJ helped with data interpretation and analysis plan. All authors read and approved the final manuscript.

Acknowledgements

We would like to acknowledge Alexandre Lussier and Nicole Gladish for their editorial contributions.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The microarray data and R code generated during the current study are available at the Stanford Digital Depository: https://purl.stanford.edu/fq418zt1728.

Ethics approval and consent to participate

The ‘Committee on Science and Ethics’ of the University of Costa Rica approved sample recruitment and sample collection, and all participants provided written informed consent. All data analyses were approved by the Administrative Panel for the Protection of Human Subjects at Stanford University.

Funding

The CRELES data were collected by the Central American Population Center of the University of Costa Rica with support from Wellcome Trust Grant 072406. We gratefully acknowledge funding for the DNAm assays from the Center on the Economics and Demography of Aging, UC Berkeley (P30AG012839). We would also like to acknowledge funding from the Canadian Institute of Health Research (CIHR) (F16-00910) and the R. Howard Webster Foundation (F13-00031). DH Rehkopf was supported by a grant from the National Institute of Aging (K01 AG047280). MS Kobor is the Canada Research Chair in Social Epigenetics, Senior Fellow of the Canadian Institute for Advanced Research, and Sunny Hill BC Leadership Chair in Child Development. LM McEwen was supported by a CIHR Frederick Banting and Charles Best Doctoral Research Award (F15-04283).

Author information

Authors and Affiliations

  1. Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, BC Children’s Hospital Research Institute, University of British Columbia, 950 West 28th Ave, Vancouver, Canada

    Lisa M. McEwen, Alexander M. Morin, Rachel D. Edgar, Julia L. MacIsaac, Meaghan J. Jones & Michael S. Kobor

  2. School of Public Health, University of California, Berkeley, Berkeley, CA, USA

    William H. Dow

  3. Centro Centroamericano de Población, Universidad de Costa Rica, San José, Costa Rica

    Luis Rosero-Bixby

  4. Division of General Medical Disciplines, Department of Medicine, School of Medicine, Stanford University, 1070 Arastradero Road, Suite 300, Palo Alto, CA, 94304, USA

    David H. Rehkopf

Authors
  1. Lisa M. McEwen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander M. Morin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rachel D. Edgar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Julia L. MacIsaac
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Meaghan J. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. William H. Dow
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Luis Rosero-Bixby
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michael S. Kobor
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. David H. Rehkopf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David H. Rehkopf.

Additional files

13072_2017_128_MOESM1_ESM.png

Additional file 1: Figure S1. Correlation plot of DNA methylation-based estimated blood cell-type proportions. Colored blocks represent correlation p values below 0.05, red indicates negative correlation and blue indicates positive correlation. Gran = granulocyte, Mono = monocyte, NK = natural killer.

13072_2017_128_MOESM2_ESM.pdf

Additional file 2: Figure S2. EEAA (extrinsic epigenetic age acceleration), General Age Acceleration (residuals from a linear model of DNAm age regressed onto chronological age), IEAA (intrinsic age acceleration). All measures were generated from the online epigenetic age software. No significant differences were observed between Nicoyans (blue) and non-Nicoyans (red). Significant values generated from ANOVA statistical tests.

13072_2017_128_MOESM3_ESM.pdf

Additional file 3: Figure S3. Continuation of differentially methylated regions between Nicoyans and non-Nicoyans. Remaining 14 of the 20 statistically significant DMRs obtained from DMRcate analysis found by the R package ‘DMRcate.’ Unadjusted DNA methylation values, shown as percent of cells methylated, are displayed on the y-axis, and genomic distance (bp) to the TSS is plotted on the × axis. Associated genes are based on closest distance to the TSS of each differentially methylation region. Nicoyans are represented by blue points with the mean of each CpG site illustrated by a blue line. Non-Nicoyans are represented with red with each point indicating an individual, with the red line illustrating the mean at each CpG.

13072_2017_128_MOESM4_ESM.pdf

Additional file 4: Figure S4. QQ plots of each identified CpG modeled using M values or β values. Linear model included DNA methylation value regressed on group (Nicoya vs non-Nicoya) with sex, age, and estimated cell-type proportions included as covariates.

13072_2017_128_MOESM5_ESM.pdf

Additional file 5: Figure S5. Epistructure-derived principal component analysis. Genetically informative 450k array sites were used to estimate genetic population structure in our data. Principal component analysis was performed on a reference CpG list to generate measures (PCs) of genetic structure. No significant difference in these estimates was seen between Nicoyans and non-Nicoyans.

Additional file 6: Table S1. Pyrosequencing primer sequences designed with Qiagen Pyromark Assay Design 2.0 software.

Additional file 7: Table S2. Comparison of M values and β values of each identified CpG.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McEwen, L.M., Morin, A.M., Edgar, R.D. et al. Differential DNA methylation and lymphocyte proportions in a Costa Rican high longevity region. Epigenetics & Chromatin 10, 21 (2017). https://doi.org/10.1186/s13072-017-0128-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13072-017-0128-2

Keywords

Epigenetics & Chromatin

ISSN: 1756-8935